Journal List > Korean J Urol > v.49(7) > 1005141

Lee, Oh, and Mah: Long-term Follow up of Augmentation Ileocystoplasty with Goodwin’s Ileal Cup Patched Bladder

Abstract

Purpose

We evaluated the long-term outcomes in patients undergoing augmentation ileocystoplasty with Goodwin’s ileal cup patched bladder.

Materials and Methods

This was a retrospective study of 72 consecutive patients who underwent augmentation ileocystoplasty because of decreased bladder capacity, vesico-ureteral reflux and urinary incontinence. The outcomes assessed included the continence status, bladder capacity, upper tract status, and significant post-operative complications.

Results

The 72 patients studied (61 men and 11 women) were 12 to 62 years old (mean age 35.6). The follow up was 0.3 to 7.9 years (mean 5.4). The preoperative diagnoses were a neurogenic bladder from spinal cord injury in 54 patients, meningomyelocele in 5, pelvic trauma in 3, poly-myelitis in 2, GU tuberculosis in 2, cerebrovascular diseases in 2, and disc rupture in 2. The bladder capacity was significantly increased from 168cc to 392cc postoperatively and the maximal bladder capacity was increased along with the decreased number of daily clean intermittent cathe-terizations. The most common complication related to surgery was a paralytic ileus. While most cases of unilateral reflux disappeared, bilateral or high grade reflux remained during the postoperative follow up period.

Conclusions

Bladder augmentation provided durable clinical and urodynamic improvement for patients with neurogenic and contracted bladders.

REFERENCES

1.Greenwell TJ., Venn SN., Mundy AR. Augmentation cystoplasty. BJU Int. 2001. 88:511–25.
crossref
2.Blaivas JG., Weiss JP., Desai P., Flisser AJ., Stember DS., Stahl PJ. Long-term followup of augmentation enterocystoplasty and continent diversion in patients with benign disease. J Urol. 2005. 173:1631–4.
crossref
3.Kurzrock EA., Baskin LS., Kogan BA. Gastrocystoplasty: long-term followup. J Urol. 1998. 160:2182–6.
crossref
4.Smith JJ 3rd., Swierzewski SJ 3rd. Augmentation cystoplasty. Urol Clin North Am. 1997. 24:745–54.
crossref
5.Chong CI., Yoon KH., Sung GT., Kwon HY., Yoon JH. An experience of augmentation gastrocystoplasty in the treatment of a child with spastic neurogenic bladder. Korean J Urol. 1995. 36:1128–34.
6.Yang KM., Jeon HJ., Han SW. The clinical experience of the ureterocystoplasty in neurogenic bladder. Korean J Urol. 2005. 46:708–12.
7.Landau EH., Jayanthi VR., Khoury AE., Churchill BM., Gilmour RF., Steckler RE, et al. Bladder augmentation: ureterocysto-plasty versus ileocystoplasty. J Urol. 1994. 152:716–9.
crossref
8.Leng WW., Blalock HJ., Fredriksson WH., English SF., McGuire EJ. Enterocystoplasty or detrusor myectomy? Comparison of indications and outcomes for bladder augmentation. J Urol. 1999. 161:758–63.
crossref
9.Goodwin WE., Winter CC., Barker WF. "Cup-patch" technique of ileocystoplasty for bladder enlargement or partial substitution. J Urol. 2002. 168:667–70.
crossref
10.Kim YB., Park WH., Shim HB. The long-term outcomes of augmentation cystoplasty in spinal cord injury patients. Korean J Urol. 2003. 44:529–33.
11.Lee JS., Mah SY. The clinical experience of the bladder augmentation with Goodwin's ileal cup-patched bladder. Korean J Urol. 2003. 44:882–8.
12.Cho MK., Song HC., Seo KS., Kim JS., Rim JS. An experience of spastic neurogenic bladder treated with augmentation cystoplasty and external urethral sphincterotomy. Korean J Urol. 1998. 39:195–9.
13.Hendren WH., Hendren RB. Bladder augmentation: experience with 129 children and young adults. J Urol. 1990. 144:445–53.
crossref
14.Gough DC. Enterocystoplasty. BJU Int. 2001. 88:739–43.
crossref
15.Khoury JM., Timmons SL., Corbel L., Webster GD. Complications of enterocystoplasty. Urology. 1992. 40:9–14.
crossref
16.Quek ML., Ginsberg DA. Long-term urodynamics followup of bladder augmentation for neurogenic bladder. J Urol. 2003. 169:195–8.
crossref
17.Simforoosh N., Tabibi A., Basiri A., Noorbala MH., Danesh AD., Ijadi A. Is ureteral reimplantation necessary during augmentation cystoplasty in patients with neurogenic bladder and vesicoureteral reflux? J Urol. 2002. 168:1439–41.
crossref
18.Hayashi Y., Kato Y., Okazaki T., Lane GJ., Kobayashi H., Yamataka A. The effectiveness of ureteric reimplantation during bladder augmentation for high-grade vesicoureteric reflux in patients with neurogenic bladder: long-term outcome. J Pediatr Surg. 2007. 42:1998–2001.
crossref
19.Guven A., Onal B., Kogan BA. Spontaneous bladder perforations following augmentation cystoplasty in children. Nat Clin Pract Urol. 2006. 3:584–5.
crossref
20.Kim JH., Park EC., Lee SE. The long-term results of augmentation cystoplasty in contracted bladder. Korean J Urol. 2001. 42:59–64.
21.Flood HD., Malhotra SJ., O'Connell HE., Ritchey MJ., Bloom DA., McGuire EJ. Long-term results and complications using augmentation cystoplasty in reconstructive urology. Neurourol Urodyn. 1995. 14:297–309.
crossref
22.Atala A. Future trends in bladder reconstructive surgery. Semin Pediatr Surg. 2002. 11:134–42.
crossref
23.Byun SS., Chung YS., Lee SS., Lee HN., Lee JY., Lee JY. Augmentation cystoplasty using hydroxapatite/chitosan composite sheet seeded with autologous muscle-derived stem cells. Korean J Urol. 2007. 48:433–8.
crossref

Fig. 1.
The flat patch of the ileum formed is pulled together in the form of a U shape and sutured together with a continuous, intermittently locking catgut sutures. After the peritoneum has been mobilized from the base of the bladder, the bladder is opened in the midline, through its vertex. The ileac patch is then sewed to the bladder beginning posterior in the midline and working laterally from each side using a continuous catgut sutures.
kju-49-598f1.tif
Table 1.
Clinical characteristics of the patients
Clinical characteristics No. of patients (%)
No. of patients 72
Mean age (years) 35.6 (12-62)
Male/female 61 (84.7)/11 (15.3)
Cause
Myelomeningocele 5 (6.9)
Spinal cord injury 54 (75)
Cervical spine 14 (19.4)
Thoracic spine 28 (38.9)
Lumbar spine 12 (16.7)
Pelvic trauma 3 (4.2)
Poliomyelitis 2 (2.8)
Rupture of intervertebral disc 2 (2.8)
Tuberculosis 2 (2.8)
Cerebrovascular disease 5 (6.9)
Table 2.
Preoperative complication and vesicoureteral reflux
Preoperative complication & vesicoureteral reflux No. of patients (%)
Preoperative complication (multiple)
Urianry incontinence 57 (79.2)
Increased times of CIC 46 (63.9)
Recurrent urinary tract infection 34 (47.2)
Autonomic dysreflexia 11 (15.3)
Preoperative vesicoureteral reflux
Bilateral 45 (62.5)
Unilateral 17 (23.6)
Anti-reflux surgery
Bilateral 6 (8.3)
Unilateral 8 (11.1)
Concurrent artificial sphincter implantation 3 (4.1)
due to internal sphincter deficiency (AMS 800 AUS)

CIC: clean intermittent catheterization, AUS: artificial urinary sphincter

Table 3.
Surgical outcomes
Mean times of CIC
Preoperative 9.3 times/day
Postoperative 6.1 times/day
Vesicoureteral reflux
Unilateral 45
Anti-relflux surgery was done 1/3
Anti-relflux surgery was not done 7/42
Bilateral 17
Anti-relflux surgery was done 4/8 (bilateral 3,
unilateral 1)
Anti-relflux surgery was not done 11/11 (bilateral 10,
unilateral 1)
Mean bladder capacity
Preoperative 168cc
Postoperative (2 months) 392cc
Postoperative (12 months or more) 453cc
Mean vesical pressure
Preoperative 55cmH2O
Postoperative (2 months) 21.5cmH2O
Postoperative (12 months or more) 20.7cmH2O

CIC: clean intermittent catheterization

Table 4.
Postoperative complications
Postoperative complications No. of patients (%)
Paralytic ileus 18 (25)
Experience of obstruction due to mucous secretion 12 (16.7)
Febrile urinary tract infection 7 (9.7)
Urinary leaking at anastomosis site 6 (8.3)
Electrolyte imbalance 4 (5.6)
Sepsis 2 (2.8)
TOOLS
Similar articles